These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 7863479)
1. Hemostatic abnormalities in acute myocardial infarction as detected by specific blood markers. Tanaka M; Suzuki A Thromb Res; 1994 Nov; 76(3):289-98. PubMed ID: 7863479 [TBL] [Abstract][Full Text] [Related]
2. Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris. Vaziri ND; Kennedy SC; Kennedy D; Gonzales E Am J Med; 1992 Dec; 93(6):651-7. PubMed ID: 1466361 [TBL] [Abstract][Full Text] [Related]
3. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen. Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490 [TBL] [Abstract][Full Text] [Related]
4. Increased heparin-releasable platelet factor 4 and D dimer in patients one month after the onset of acute myocardial infarction: persistent activation of platelets and the coagulation/fibrinolytic system. Abe S; Maruyama I; Arima S; Yamaguchi H; Okino H; Hamasaki S; Yamashita T; Nomoto K; Tahara M; Atsuchi Y Int J Cardiol; 1994 Dec; 47(1 Suppl):S7-12. PubMed ID: 7737755 [TBL] [Abstract][Full Text] [Related]
5. Absence of paradoxical thrombin activation by fibrin-specific thrombolytics in acute myocardial infarction: comparison of single-bolus tenecteplase and front-loaded alteplase. Szabo S; Letsch R; Ehlers R; Walter T; Kazmaier S; Helber U; Hoffmeister HM Thromb Res; 2002 Apr; 106(2):113-9. PubMed ID: 12182909 [TBL] [Abstract][Full Text] [Related]
6. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases]. Shibata T; Ishii T; Tomo T; Kaneko K; Nasu M; Magari Y; Fukushima K Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):373-8. PubMed ID: 1831516 [TBL] [Abstract][Full Text] [Related]
7. Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood. Kalweit GA; Feindt P; Micek M; Gams E; Hellstern P Thromb Res; 2000 Feb; 97(3):105-11. PubMed ID: 10680641 [TBL] [Abstract][Full Text] [Related]
8. Thrombin generation as an acute effect of cigarette smoking. Kimura S; Nishinaga M; Ozawa T; Shimada K Am Heart J; 1994 Jul; 128(1):7-11. PubMed ID: 8017287 [TBL] [Abstract][Full Text] [Related]
9. High-molecular-weight kininogen and the intrinsic coagulation pathway in patients with de novo acute myocardial infarction. Cubedo J; Ramaiola I; Padró T; Martin-Yuste V; Sabate-Tenas M; Badimon L Thromb Haemost; 2013 Dec; 110(6):1121-34. PubMed ID: 24096571 [TBL] [Abstract][Full Text] [Related]
10. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis. Kario K; Matsuo T Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090 [TBL] [Abstract][Full Text] [Related]
11. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction. Scharfstein JS; Abendschein DR; Eisenberg PR; George D; Cannon CP; Becker RC; Sobel B; Cupples LA; Braunwald E; Loscalzo J Am J Cardiol; 1996 Sep; 78(5):503-10. PubMed ID: 8806332 [TBL] [Abstract][Full Text] [Related]
12. Increased tissue factor pathway inhibitor in patients with acute myocardial infarction. Kamikura Y; Wada H; Yamada A; Shimura M; Hiyoyama K; Shiku H; Tanigawa M; Nishikawa H; Yamada N; Isaka N; Nakano T; Kumeda K; Kato H Am J Hematol; 1997 Aug; 55(4):183-7. PubMed ID: 9257877 [TBL] [Abstract][Full Text] [Related]
13. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors. Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363 [TBL] [Abstract][Full Text] [Related]
14. Fluctuation of thrombin-antithrombin III complex in patients with acute myocardial infarction: influence of low-dose heparin administration. Psuja P; Lewandowski K; Turowiecka Z; Zozulińska M; Tokarz A; Zawilska K Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):229-36. PubMed ID: 1697824 [TBL] [Abstract][Full Text] [Related]
16. Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state. Ariëns RA; de Lange M; Snieder H; Boothby M; Spector TD; Grant PJ Lancet; 2002 Feb; 359(9307):667-71. PubMed ID: 11879863 [TBL] [Abstract][Full Text] [Related]
17. Hemostatic markers in ischemic stroke of undetermined etiology. Ince B; Bayram C; Harmanci H; Ulutin T Thromb Res; 1999 Nov; 96(3):169-74. PubMed ID: 10588458 [TBL] [Abstract][Full Text] [Related]
18. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer. Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S Cancer; 1993 Oct; 72(7):2134-40. PubMed ID: 7690680 [TBL] [Abstract][Full Text] [Related]
19. [Changes in coagulation and fibrinolysis in the patients with coronary heart disease in acute period and effect of drug intervention]. Jia XQ; Dong CM; Qin J; Zhang L Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr; 24(4):225-8. PubMed ID: 22464576 [TBL] [Abstract][Full Text] [Related]